267 related articles for article (PubMed ID: 27398720)
1. Exenatide Treatment Alone Improves β-Cell Function in a Canine Model of Pre-Diabetes.
Ionut V; Woolcott OO; Mkrtchyan HJ; Stefanovski D; Kabir M; Iyer MS; Liu H; Castro AV; Wu Q; Broussard JL; Kolka CM; Asare-Bediako I; Bergman RN
PLoS One; 2016; 11(7):e0158703. PubMed ID: 27398720
[TBL] [Abstract][Full Text] [Related]
2. Hepatic portal vein denervation impairs oral glucose tolerance but not exenatide's effect on glycemia.
Ionut V; Castro AV; Woolcott OO; Stefanovski D; Iyer MS; Broussard JL; Burch M; Elazary R; Kolka CM; Mkrtchyan H; Bediako IA; Bergman RN
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E644-52. PubMed ID: 25117408
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunction.
Armato J; DeFronzo RA; Abdul-Ghani M; Ruby R
Endocr Pract; 2012; 18(3):342-50. PubMed ID: 22068250
[TBL] [Abstract][Full Text] [Related]
4. Effect of exenatide on splanchnic and peripheral glucose metabolism in type 2 diabetic subjects.
Cersosimo E; Gastaldelli A; Cervera A; Wajcberg E; Sriwijilkamol A; Fernandez M; Zuo P; Petz R; Triplitt C; Musi N; DeFronzo RA
J Clin Endocrinol Metab; 2011 Jun; 96(6):1763-70. PubMed ID: 21411546
[TBL] [Abstract][Full Text] [Related]
5. The effect of chronic twice daily exenatide treatment on β-cell function in new onset type 2 diabetes.
Gastaldelli A; Brodows RG; D'Alessio D
Clin Endocrinol (Oxf); 2014 Apr; 80(4):545-53. PubMed ID: 23574529
[TBL] [Abstract][Full Text] [Related]
6. Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes.
Schnabel CA; Wintle M; Kolterman O
Vasc Health Risk Manag; 2006; 2(1):69-77. PubMed ID: 17319471
[TBL] [Abstract][Full Text] [Related]
7. One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial.
Bunck MC; Diamant M; Cornér A; Eliasson B; Malloy JL; Shaginian RM; Deng W; Kendall DM; Taskinen MR; Smith U; Yki-Järvinen H; Heine RJ
Diabetes Care; 2009 May; 32(5):762-8. PubMed ID: 19196887
[TBL] [Abstract][Full Text] [Related]
8. Effect of exenatide on postprandial glucose fluxes, lipolysis, and ß-cell function in non-diabetic, morbidly obese patients.
Camastra S; Astiarraga B; Tura A; Frascerra S; Ciociaro D; Mari A; Gastaldelli A; Ferrannini E
Diabetes Obes Metab; 2017 Mar; 19(3):412-420. PubMed ID: 27898183
[TBL] [Abstract][Full Text] [Related]
9. Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor.
Tatarkiewicz K; Sablan EJ; Polizzi CJ; Villescaz C; Parkes DG
Am J Physiol Regul Integr Comp Physiol; 2014 Apr; 306(7):R490-8. PubMed ID: 24477544
[TBL] [Abstract][Full Text] [Related]
10. Novel canine models of obese prediabetes and mild type 2 diabetes.
Ionut V; Liu H; Mooradian V; Castro AV; Kabir M; Stefanovski D; Zheng D; Kirkman EL; Bergman RN
Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E38-48. PubMed ID: 19843874
[TBL] [Abstract][Full Text] [Related]
11. The GLP-1 analogue exenatide improves hepatic and muscle insulin sensitivity in diabetic rats: tracer studies in the basal state and during hyperinsulinemic-euglycemic clamp.
Wu H; Sui C; Xu H; Xia F; Zhai H; Zhang H; Weng P; Han B; Du S; Lu Y
J Diabetes Res; 2014; 2014():524517. PubMed ID: 25580440
[TBL] [Abstract][Full Text] [Related]
12. Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes.
Rosenstock J; Klaff LJ; Schwartz S; Northrup J; Holcombe JH; Wilhelm K; Trautmann M
Diabetes Care; 2010 Jun; 33(6):1173-5. PubMed ID: 20332357
[TBL] [Abstract][Full Text] [Related]
13. Sustained metabolic benefits of ΔTRTX-Ac1, a tarantula venom-derived peptide, when administered together with exenatide in high-fat fed mice.
Coulter-Parkhill A; Tanday N; Cobice D; McLaughlin CM; McClean S; Gault VA; Irwin N
Diabetes Obes Metab; 2024 Jan; 26(1):329-338. PubMed ID: 37818589
[TBL] [Abstract][Full Text] [Related]
14. Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes.
Derosa G; Franzetti IG; Querci F; Carbone A; Ciccarelli L; Piccinni MN; Fogari E; Maffioli P
Diabet Med; 2012 Dec; 29(12):1515-23. PubMed ID: 22540883
[TBL] [Abstract][Full Text] [Related]
15. Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus.
Briones M; Bajaj M
Expert Opin Pharmacother; 2006 Jun; 7(8):1055-64. PubMed ID: 16722815
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of exenatide monotherapy in obese patients with newly diagnosed type 2 diabetes: a randomized, 26 weeks metformin-controlled, parallel-group study.
Yuan GH; Song WL; Huang YY; Guo XH; Gao Y
Chin Med J (Engl); 2012 Aug; 125(15):2677-81. PubMed ID: 22931974
[TBL] [Abstract][Full Text] [Related]
17. Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.
Derosa G; Franzetti IG; Querci F; Carbone A; Ciccarelli L; Piccinni MN; Fogari E; Maffioli P
Pharmacotherapy; 2013 Aug; 33(8):817-26. PubMed ID: 23744726
[TBL] [Abstract][Full Text] [Related]
18. Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System.
Daniele G; Iozzo P; Molina-Carrion M; Lancaster J; Ciociaro D; Cersosimo E; Tripathy D; Triplitt C; Fox P; Musi N; DeFronzo R; Gastaldelli A
Diabetes; 2015 Oct; 64(10):3406-12. PubMed ID: 26116695
[TBL] [Abstract][Full Text] [Related]
19. Effects of exenatide vs. metformin on endothelial function in obese patients with pre-diabetes: a randomized trial.
Kelly AS; Bergenstal RM; Gonzalez-Campoy JM; Katz H; Bank AJ
Cardiovasc Diabetol; 2012 Jun; 11():64. PubMed ID: 22681705
[TBL] [Abstract][Full Text] [Related]
20. Exendin-4 potentiates insulinotropic action partly via increasing beta-cell proliferation and neogenesis and decreasing apoptosis in association with the attenuation of endoplasmic reticulum stress in islets of diabetic rats.
Kwon DY; Kim YS; Ahn IS; Kim DS; Kang S; Hong SM; Park S
J Pharmacol Sci; 2009 Dec; 111(4):361-71. PubMed ID: 20019445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
